HYPERKALEMIC CHANGES DURING SPIRONOLACTONE THERAPY FOR CIRRHOSIS AND ASCITES, WITH SPECIAL REFERENCE TO HYPERKALEMIC INTERMITTENT PARALYSIS
- 1 August 1968
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 16 (8) , 874-886
- https://doi.org/10.1111/j.1532-5415.1968.tb02682.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- THERAPY WITH COMBINATIONS OF DIURETIC AGENTS: COMPARATIVE STUDIES*Annals of the New York Academy of Sciences, 1966
- ALDOSTERONE ANTAGONISTS AND TRIAMTERENE*Annals of the New York Academy of Sciences, 1966
- THE COMPLICATIONS OF DIURETIC THERAPY IN PATIENTS WITH CIRRHOSISAnnals of the New York Academy of Sciences, 1966
- Hyperkalemic Effects of TriamtereneAnnals of Internal Medicine, 1966
- Use of Modern DiureticsCirculation, 1966
- Renal failure in patients with cirrhosis of the liverThe American Journal of Medicine, 1965
- Body and Serum Potassium in Liver DiseaseGastroenterology, 1965
- Small-Bowel Ulceration Apparently Associated With Thiazide and Potassium TherapyJAMA, 1964
- Significance of aldosterone antagonism in the treatment of edema and ascitesThe American Journal of Medicine, 1962
- Use of Spironolactone in Renal EdemaPublished by American Medical Association (AMA) ,1961